Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Chulalongkorn University is currently managing 1 pending office action within the Biotechnology & Pharmaceuticals technology area. This matter is assigned to 1 distinct examiner, showing a concentrated effort in the university's patent prosecution. The activity is confined to 1 distinct art unit, which suggests a specific technical focus for the university's current intellectual property pursuits. This focused engagement within 1 distinct art unit and with 1 distinct examiner streamlines the university's administrative burden during the patent acquisition process.
REGLAS, GILLIAN CHELSEA is the busiest examiner for the university, with 1 busiest examiner pending action. Because this examiner is the 1 individual currently reviewing a pending action, the university's immediate success in this technology area is tied to this 1 examiner's examination style. The presence of 1 pending office action indicates a low volume of active prosecution, allowing for a specialized response to the examiner's requirements. With 1 pending office action to consider, the university can tailor its arguments to the specific feedback received from REGLAS, GILLIAN CHELSEA. This level of concentration ensures that the university's resources are not spread across multiple competing patent office priorities.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Multi-statute (no §101) | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| REGLAS, GILLIAN CHELSEA | 1 | 30.2% | +41.5% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17995971 | A Composition and A Method of Rejuvenating DNA and Preventing DNA Damage | REGLAS, GILLIAN CHELSEA | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17995971 | A Composition and A Method of Rejuvenating DNA and Preventing DNA Damage | REGLAS, GILLIAN CHELSEA | — |
| Art Unit | Apps |
|---|---|
| 1632 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 17995971 | A Composition and A Method of Rejuvenating DNA and Preventing DNA Damage | REGLAS, GILLIAN CHELSEA | 1632 | §103§112 | Non-Final OA | — | Pending | Oct 11, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial